Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS42000023EBVENSG00000177272.10protein_codingKCNA3NoNo3738P22001
TVIS30001593HIVENSG00000177272.10protein_codingKCNA3NoNo3738P22001
TVIS30001594HIVENSG00000177272.10protein_codingKCNA3NoNo3738P22001
TVIS30011288HIVENSG00000177272.10protein_codingKCNA3NoNo3738P22001
TVIS30019016HIVENSG00000177272.10protein_codingKCNA3NoNo3738P22001
TVIS30024696HIVENSG00000177272.10protein_codingKCNA3NoNo3738P22001
TVIS30024697HIVENSG00000177272.10protein_codingKCNA3NoNo3738P22001
TVIS44015520HTLV-1ENSG00000177272.10protein_codingKCNA3NoNo3738P22001
TCGA Plot Options
Drug Information
GeneKCNA3
DrugBank IDDB00845
Drug NameClofazimine
Target IDBE0004716
UniProt IDP22001
Regulation Typeantagonist
PubMed IDs22020137
CitationsCholo MC, Steel HC, Fourie PB, Germishuizen WA, Anderson R: Clofazimine: current status and future prospects. J Antimicrob Chemother. 2012 Feb;67(2):290-8. doi: 10.1093/jac/dkr444. Epub 2011 Oct 20.
GroupsApproved; Investigational
Direct ClassificationPhenazines and derivatives
SMILESCC(C)N=C1C=C2N(C3=CC=C(Cl)C=C3)C3=C(C=CC=C3)N=C2C=C1NC1=CC=C(Cl)C=C1
Pathways
PharmGKBPA164748759
ChEMBLCHEMBL1292